Prognostic implication of CEACAM1 expression in squamous cell carcinoma of the larynx: Pilot study.
Guendalina LucariniAntonio ZizziMassimo ReMd Abu SayeedRoberto Di PrimioCorrado RubiniPublished in: Head & neck (2018)
Our study is the first to demonstrate that CEACAM1 expression is associated with an adverse prognosis in LSCC. CEACAM1 is a valuable biomarker and a promising therapeutic target in LSCC.